newsfilter
← Latest News
GlobeNewswire·

Quince Therapeutics to Participate in September 2026 Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (NASDAQ:QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for